Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo
Book Now
Menu
Book Now

Dr. Tomoya Takenaka, PhD
Principal Scientist, Drug Product and Device Development at Takeda Pharmaceutical Company
Speaker

Profile

Dr. Tomoya Takenaka has over 15 years of experience in CMC formulation development at Takeda Pharmaceutical Company, with extensive involvement in injectable drug product development from preclinical stages to NDA/BLA submission. He holds a Ph.D. in Science from Osaka Prefecture University, focusing on exosome research, and has an academic background in Material Engineering from the University of Tokyo, where he studied polymeric micelle-based drug delivery systems.

Agenda Sessions

  • Formulation Innovations for Future Oligonucleotide Therapies: Insights Inspired by Biologics

    , 11:00am
    View Session

At this event

Prev
Next
Hiroshi Abe, PhD
Professor, Department of Chemistry, Graduate School
Nagoya University

See Tomoya at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now